These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3072426)

  • 1. Protein engineering in studies on metabolism of toxic substances.
    Imai Y
    J Toxicol Sci; 1988 Nov; 13(4):290-5. PubMed ID: 3072426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future.
    Crespi CL; Miller VP
    Pharmacol Ther; 1999 Nov; 84(2):121-31. PubMed ID: 10596902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Georges Brohee Prize 1996. Major cytochrome P-450 families: implications in health and liver diseases.
    Horsmans Y
    Acta Gastroenterol Belg; 1997; 60(1):2-10. PubMed ID: 9144971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of two cytochrome P-450s within the mouse, male-specific steroid 16 alpha-hydroxylase gene family: expression in mammalian cells and chimeric proteins.
    Ichikawa T; Itakura T; Negishi M
    Biochemistry; 1989 May; 28(11):4779-84. PubMed ID: 2788458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
    Kitamura S; Sugihara K
    Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered in vitro systems for biotransformation studies.
    Doehmer J; Schmalix WA; Greim H
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):513-8. PubMed ID: 7885078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction.
    Gonzalez FJ
    NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of drug-metabolizing enzymes: mechanisms and consequences.
    Okey AB; Roberts EA; Harper PA; Denison MS
    Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term preservation and induction of drug metabolizing enzymes in co-cultured rat hepatocytes.
    Akrawi M; Rogiers V; Vercruysse A; Phillips IR; Shephard EA
    Biochem Soc Trans; 1994 May; 22(2):124S. PubMed ID: 7958195
    [No Abstract]   [Full Text] [Related]  

  • 10. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
    Prandota J
    Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of rabbit liver cytochrome P-450 (laurate omega-1 hydroxylase) synthesized in transformed yeast cells.
    Imai Y
    J Biochem; 1988 Jan; 103(1):143-8. PubMed ID: 3283112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease.
    Gonzalez FJ; Gelboin HV
    J Toxicol Environ Health; 1993; 40(2-3):289-308. PubMed ID: 8230303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytochrome p450 and their implication in chemotherapy].
    Delwaide PA
    Rev Med Liege; 1998 Nov; 53(11):700-10. PubMed ID: 9887664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of regions functioning in substrate interaction of rabbit liver cytochrome P-450 (laurate (omega-1)-hydroxylase).
    Uno T; Imai Y
    J Biochem; 1989 Oct; 106(4):569-74. PubMed ID: 2691506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions: Proteins, pumps, and P-450s.
    Shapiro LE; Shear NH
    J Am Acad Dermatol; 2002 Oct; 47(4):467-84; quiz 485-8. PubMed ID: 12271287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug metabolism catalyzed by cytochrome P-450].
    Nagata K
    Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):146-8. PubMed ID: 19749487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.